Exploring Merkel Cell Carcinoma Clinical Trial Engagement Patterns

Starting soon

Conditions studied: Merkel Cell Carcinoma

In brief

Taking part in medical research usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This study will admit a wide range of data on the clinical trial experience of Merkel cell carcinoma patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future Merkel cell carcinoma patients.

Key facts

Study ID

NCT06039033

Run by

Power Life Sciences Inc.

People needed

500

Starts

2024-10-01

Expected to finish

2026-10-01

Last updated by the study team

2023-09-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Aged ≥ 18 years old
• Able to comprehend the investigational nature of the protocol and provide informed consent
• Diagnosis of Merkel cell carcinoma

You may not qualify if…

• No diagnosis of Merkel cell carcinoma confirmed
• Inability to perform regular electronic reporting
• Patient does not understand, sign, and return consent form

Where it is running

• Power Life Sciences — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.